CTSO Cytosorbents | $0.94
-6.9% | 5/2/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 5/2/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 5/2/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $9.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 5/2/2025 |
TTI TETRA Technologies | $2.76
+4.2% | 5/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $4.00 | High | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 5/1/2025 |
LUNG Pulmonx | $3.77
| 5/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 5/1/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/30/2025 |
IMUX Immunic | $1.15
-1.7% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/30/2025 |
VNRX VolitionRx | $0.48
-2.6% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 4/30/2025 |
GFAI Guardforce AI | $1.02
-3.3% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | Low | View details for D. Boral Capital rating of Guardforce AI (NASDAQ:GFAI) on 4/28/2025 |
TVGN Tevogen Bio | $1.01
+3.2% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 4/29/2025 |
CNTX Context Therapeutics | $0.87
+0.8% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/29/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
MDCX Medicus Pharma | $4.41
+2.1% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/28/2025 |
CMPX Compass Therapeutics | $1.89
+3.8% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | Medium | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/28/2025 |
VERI Veritone | $2.04
+0.5% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 4/28/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 4/28/2025 |
CODX Co-Diagnostics | $0.37
+0.8% | 4/28/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $10.00 | Medium | View details for D. Boral Capital rating of Co-Diagnostics (NASDAQ:CODX) on 4/28/2025 |
RVPH Reviva Pharmaceuticals | $0.87
-0.7% | 4/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/24/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 4/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/23/2025 |
UAMY United States Antimony | $3.40
+5.6% | 4/23/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $5.00 | Low | View details for D. Boral Capital rating of United States Antimony (NYSE:UAMY) on 4/23/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/22/2025 |
OSTX OS Therapies | $2.04
+5.7% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/22/2025 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/21/2025 |
MDCX Medicus Pharma | $4.41
+2.1% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/21/2025 |
CMPX Compass Therapeutics | $1.89
+3.8% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/21/2025 |
TVGN Tevogen Bio | $1.01
+3.2% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 4/21/2025 |
HOVR New Horizon Aircraft | $0.52
+4.5% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 4/21/2025 |
NNOX Nano-X Imaging | $5.15
+3.2% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 4/17/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 4/17/2025 |
ADUR Aduro Clean Technologies | $5.55
+7.4% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 4/17/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 4/15/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/15/2025 |
MDCX Medicus Pharma | $4.41
+2.1% | 4/14/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/14/2025 |
SCLX Scilex | $5.44
+6.7% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/11/2025 |
OMER Omeros | $7.17
+2.1% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/11/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 4/10/2025 |
ANIX Anixa Biosciences | $2.78
-0.4% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 4/10/2025 |
IMUX Immunic | $1.15
-1.7% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/10/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 4/10/2025 |
CNTX Context Therapeutics | $0.87
+0.8% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/9/2025 |
MNOV MediciNova | $1.51
+2.7% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 4/9/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/9/2025 |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
FBLG FibroBiologics | $1.01
-1.0% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/9/2025 |
CRMD CorMedix | $9.38
-2.8% | 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 4/8/2025 |
CLNN Clene | $2.98
-0.7% | 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 4/8/2025 |
OSTX OS Therapies | $2.04
+5.7% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/7/2025 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 4/7/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 4/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 4/4/2025 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 4/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/3/2025 |
SCLX Scilex | $5.44
+6.7% | 4/2/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $630.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/2/2025 |
PED PEDEVCO | $0.56
+1.5% | 4/2/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | High | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 4/2/2025 |
MSAI MultiSensor AI | $0.77
+8.6% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 -> $2.50 | Medium | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 4/1/2025 |
FBLG FibroBiologics | $1.01
-1.0% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/1/2025 |
CTSO Cytosorbents | $0.94
-6.9% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 4/1/2025 |
CARM Carisma Therapeutics | $0.25
+23.7% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $1.00 | High | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 4/1/2025 |
RVPH Reviva Pharmaceuticals | $0.87
-0.7% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $8.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/1/2025 |
IMUX Immunic | $1.15
-1.7% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/1/2025 |
CMPX Compass Therapeutics | $1.89
+3.8% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/1/2025 |
OMER Omeros | $7.17
+2.1% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/1/2025 |
NNOX Nano-X Imaging | $5.15
+3.2% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 3/31/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/31/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/31/2025 |
OSTX OS Therapies | $2.04
+5.7% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 3/31/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/31/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/31/2025 |
CKPT Checkpoint Therapeutics | $4.12
| 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.80 -> $4.80 | Low | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/31/2025 |
VNRX VolitionRx | $0.48
-2.6% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/31/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 3/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 3/28/2025 |
PSTV Plus Therapeutics | $0.65
-0.3% | 3/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 3/28/2025 |
CLGN CollPlant Biotechnologies | $2.14
-1.8% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | Low | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 3/27/2025 |
EVTL Vertical Aerospace | $4.03
+6.1% | 3/27/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $15.00 | Medium | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/27/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/27/2025 |
HUMA Humacyte | $1.31
-7.1% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/26/2025 |
TTI TETRA Technologies | $2.76
+4.2% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | High | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 3/26/2025 |
ANIX Anixa Biosciences | $2.78
-0.4% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/26/2025 |
CRVO CervoMed | $10.25
-2.9% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/26/2025 |
MVIS MicroVision | $1.10
+0.9% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $3.00 | High | View details for D. Boral Capital rating of MicroVision (NASDAQ:MVIS) on 3/25/2025 |
CRMD CorMedix | $9.38
-2.8% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/25/2025 |
QNCX Quince Therapeutics | $1.06
-1.9% | 3/25/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/24/2025 |
IMNN Imunon | $0.84
-0.3% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 3/24/2025 |
CLNN Clene | $2.98
-0.7% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
OMER Omeros | $7.17
+2.1% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 3/21/2025 |
CNTX Context Therapeutics | $0.87
+0.8% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
VNRX VolitionRx | $0.48
-2.6% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/20/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/20/2025 |
IVVD Invivyd | $0.63
+3.5% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/20/2025 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
BMEA Biomea Fusion | $2.18
+7.4% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 3/19/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/18/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 3/18/2025 |
CRVO CervoMed | $10.25
-2.9% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/17/2025 |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2025 |
VERI Veritone | $2.04
+0.5% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
NOTE FiscalNote | $0.65
+4.7% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 3/17/2025 |
PSTV Plus Therapeutics | $0.65
-0.3% | 3/17/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Plus Therapeutics (NASDAQ:PSTV) on 3/17/2025 |
MNOV MediciNova | $1.51
+2.7% | 3/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 3/14/2025 |
USEG U.S. Energy | $1.13
-2.6% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 3/13/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
PED PEDEVCO | $0.56
+1.5% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 3/13/2025 |
CLNN Clene | $2.98
-0.7% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
VNRX VolitionRx | $0.48
-2.6% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/12/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-2.6% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
TVGN Tevogen Bio | $1.01
+3.2% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/11/2025 |
CRVO CervoMed | $10.25
-2.9% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/11/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/10/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 3/10/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/10/2025 |
CKPT Checkpoint Therapeutics | $4.12
| 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $4.80 | High | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/10/2025 |
LUNG Pulmonx | $3.77
| 3/10/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Low | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 3/10/2025 |
HUMA Humacyte | $1.31
-7.1% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/7/2025 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/7/2025 |
CXDO Crexendo | $5.16
+1.4% | 3/6/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $7.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 3/6/2025 |
ADUR Aduro Clean Technologies | $5.55
+7.4% | 3/6/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 3/6/2025 |
CRMD CorMedix | $9.38
-2.8% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/5/2025 |
IVVD Invivyd | $0.63
+3.5% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/5/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/4/2025 |
VNRX VolitionRx | $0.48
-2.6% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/4/2025 |
TVGN Tevogen Bio | $1.01
+3.2% | 3/4/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $10.00 | High | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/4/2025 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 3/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/3/2025 |
SCLX Scilex | $5.44
+6.7% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $770.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 2/28/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/28/2025 |
FBLG FibroBiologics | $1.01
-1.0% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Low | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/27/2025 |
IMNN Imunon | $0.84
-0.3% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/27/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 2/27/2025 |
TTI TETRA Technologies | $2.76
+4.2% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 2/27/2025 |
MSAI MultiSensor AI | $0.77
+8.6% | 2/26/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/26/2025 |
IMUX Immunic | $1.15
-1.7% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/26/2025 |
HUMA Humacyte | $1.31
-7.1% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/26/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/26/2025 |
NOTE FiscalNote | $0.65
+4.7% | 2/25/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.75 | Low | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 2/25/2025 |
NNOX Nano-X Imaging | $5.15
+3.2% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 2/25/2025 |
CMPX Compass Therapeutics | $1.89
+3.8% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 2/25/2025 |
CTSO Cytosorbents | $0.94
-6.9% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2025 |
CLNN Clene | $2.98
-0.7% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 2/24/2025 |
IVVD Invivyd | $0.63
+3.5% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/24/2025 |
MNOV MediciNova | $1.51
+2.7% | 2/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 2/21/2025 |
OMER Omeros | $7.17
+2.1% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 2/20/2025 |
IMUX Immunic | $1.15
-1.7% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/20/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 2/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $22.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/20/2025 |
OSTX OS Therapies | $2.04
+5.7% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 2/20/2025 |
Gold Hits New Highs as Global Markets Spiral (Ad) When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839.
Now… as new tariffs take effect, gold is breaking records again.
You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER. Go Here to Learn What's Happening and How to Prepare >> |
IMNN Imunon | $0.84
-0.3% | 2/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/19/2025 |
CRVO CervoMed | $10.25
-2.9% | 2/19/2025 | Upgraded by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/19/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/18/2025 |
MSAI MultiSensor AI | $0.77
+8.6% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | High | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/18/2025 |
ESLA Estrella Immunopharma | $1.16
+1.8% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/18/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/18/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/14/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/14/2025 |
FBLG FibroBiologics | $1.01
-1.0% | 2/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/12/2025 |
CLGN CollPlant Biotechnologies | $2.14
-1.8% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/12/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/12/2025 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/12/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-2.6% | 2/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 2/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 2/11/2025 |
ANVS Annovis Bio | $1.62
+2.9% | 2/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | High | View details for D. Boral Capital rating of Annovis Bio (NYSE:ANVS) on 2/10/2025 |
MVIS MicroVision | $1.10
+0.9% | 2/10/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $3.00 | High | View details for D. Boral Capital rating of MicroVision (NASDAQ:MVIS) on 2/10/2025 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 2/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 2/7/2025 |
VNRX VolitionRx | $0.48
-2.6% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 2/6/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
CLNN Clene | $2.98
-0.7% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/6/2025 |
QNCX Quince Therapeutics | $1.06
-1.9% | 2/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 2/5/2025 |
CLGN CollPlant Biotechnologies | $2.14
-1.8% | 2/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/4/2025 |
IVVD Invivyd | $0.63
+3.5% | 2/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/3/2025 |
VERI Veritone | $2.04
+0.5% | 2/3/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/3/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 1/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/31/2025 |
OSTX OS Therapies | $2.04
+5.7% | 1/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/30/2025 |
VNRX VolitionRx | $0.48
-2.6% | 1/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/29/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/28/2025 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/27/2025 |
IVVD Invivyd | $0.63
+3.5% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/27/2025 |
SCLX Scilex | $5.44
+6.7% | 1/27/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $770.00 | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 1/27/2025 |
IMNN Imunon | $0.84
-0.3% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 1/24/2025 |
USEG U.S. Energy | $1.13
-2.6% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | Low | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/24/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 1/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/23/2025 |
KAPA Kairos Pharma | $0.81
+3.6% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 1/22/2025 |
ANIX Anixa Biosciences | $2.78
-0.4% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/22/2025 |
CRMD CorMedix | $9.38
-2.8% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/22/2025 |
COYA Coya Therapeutics | $6.37
+1.4% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/21/2025 |
HUMA Humacyte | $1.31
-7.1% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/21/2025 |
RVPH Reviva Pharmaceuticals | $0.87
-0.7% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/21/2025 |
CXDO Crexendo | $5.16
+1.4% | 1/21/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $7.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 1/21/2025 |
OMER Omeros | $7.17
+2.1% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 1/16/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/16/2025 |
NOTE FiscalNote | $0.65
+4.7% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 1/16/2025 |
GOVX GeoVax Labs | $1.01
+2.1% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/16/2025 |
URGN UroGen Pharma | $11.51
+0.9% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/15/2025 |
OSTX OS Therapies | $2.04
+5.7% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/15/2025 |
HOVR New Horizon Aircraft | $0.52
+4.5% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/15/2025 |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
CNTX Context Therapeutics | $0.87
+0.8% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 1/15/2025 |
ANIX Anixa Biosciences | $2.78
-0.4% | 1/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/14/2025 |
HUMA Humacyte | $1.31
-7.1% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/13/2025 |
CARM Carisma Therapeutics | $0.25
+23.7% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 1/13/2025 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/13/2025 |
CKPT Checkpoint Therapeutics | $4.12
| 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $9.00 | Medium | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/13/2025 |
CRMD CorMedix | $9.38
-2.8% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $15.00 | Low | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/13/2025 |
USEG U.S. Energy | $1.13
-2.6% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/13/2025 |
CTSO Cytosorbents | $0.94
-6.9% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/13/2025 |
BMEA Biomea Fusion | $2.18
+7.4% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $128.00 -> $128.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 1/10/2025 |
IVVD Invivyd | $0.63
+3.5% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/10/2025 |
HOVR New Horizon Aircraft | $0.52
+4.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | Low | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/8/2025 |
VNRX VolitionRx | $0.48
-2.6% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/8/2025 |
CMPX Compass Therapeutics | $1.89
+3.8% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 1/8/2025 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 1/8/2025 |
TTI TETRA Technologies | $2.76
+4.2% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 1/8/2025 |
RCEL AVITA Medical | $9.24
-1.1% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 1/8/2025 |
HOTH Hoth Therapeutics | $0.89
-0.3% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 1/7/2025 |
IMUX Immunic | $1.15
-1.7% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 1/7/2025 |
AREC American Resources | $0.83
-8.8% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 1/7/2025 |
IBRX ImmunityBio | $2.54
+2.0% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/6/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/6/2025 |
NNOX Nano-X Imaging | $5.15
+3.2% | 1/6/2025 | Initiated by | D. Boral Capital | - | Buy | $23.00 | N/A | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 1/6/2025 |
CTSO Cytosorbents | $0.94
-6.9% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/3/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-2.6% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 1/3/2025 |
USEG U.S. Energy | $1.13
-2.6% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/3/2025 |
QNCX Quince Therapeutics | $1.06
-1.9% | 1/2/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 1/2/2025 |
NRXP NRx Pharmaceuticals | $2.05
-1.4% | 12/31/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 12/31/2024 |
HOVR New Horizon Aircraft | $0.52
+4.5% | 12/30/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 12/30/2024 |
FBLG FibroBiologics | $1.01
-1.0% | 12/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 12/27/2024 |
RCEL AVITA Medical | $9.24
-1.1% | 12/24/2024 | Initiated by | D. Boral Capital | - | Buy | $25.00 | N/A | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 12/23/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/23/2024 |
CMPX Compass Therapeutics | $1.89
+3.8% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $32.00 | N/A | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 12/23/2024 |
OMER Omeros | $7.17
+2.1% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $36.00 | N/A | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 12/23/2024 |
IBRX ImmunityBio | $2.54
+2.0% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 12/20/2024 |
RZLV Rezolve AI | $2.26
+3.2% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for D. Boral Capital rating of Rezolve AI (NASDAQ:RZLV) on 12/20/2024 |
HUMA Humacyte | $1.31
-7.1% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
IMNN Imunon | $0.84
-0.3% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
CLNN Clene | $2.98
-0.7% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/19/2024 |
COYA Coya Therapeutics | $6.37
+1.4% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/18/2024 |
GOVX GeoVax Labs | $1.01
+2.1% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 12/18/2024 |
TTI TETRA Technologies | $2.76
+4.2% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | N/A | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 12/17/2024 |
BMEA Biomea Fusion | $2.18
+7.4% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/17/2024 |
ICFI ICF International | $79.86
-6.4% | 12/16/2024 | Reiterated by | D. Boral Capital | - | Outperform -> Outperform | $174.00 -> $174.00 | N/A | View details for D. Boral Capital rating of ICF International (NASDAQ:ICFI) on 12/16/2024 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 12/12/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 12/11/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/11/2024 |
CLNN Clene | $2.98
-0.7% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/10/2024 |
VNRX VolitionRx | $0.48
-2.6% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 12/10/2024 |
IMNN Imunon | $0.84
-0.3% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/10/2024 |
CRVO CervoMed | $10.25
-2.9% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 12/10/2024 |
BMEA Biomea Fusion | $2.18
+7.4% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
CARM Carisma Therapeutics | $0.25
+23.7% | 12/9/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $24.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 12/9/2024 |
URGN UroGen Pharma | $11.51
+0.9% | 12/6/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 12/6/2024 |
TRVI Trevi Therapeutics | $6.99
+1.3% | 12/4/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
COYA Coya Therapeutics | $6.37
+1.4% | 12/4/2024 | Initiated by | D. Boral Capital | - | Buy | $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/4/2024 |
ENLV Enlivex Therapeutics | $1.04
-1.0% | 12/3/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/3/2024 |
MNOV MediciNova | $1.51
+2.7% | 12/2/2024 | Initiated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 12/2/2024 |
CRVO CervoMed | $10.25
-2.9% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 11/27/2024 |
CLGN CollPlant Biotechnologies | $2.14
-1.8% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/27/2024 |
AVXL Anavex Life Sciences | $9.36
+0.5% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/25/2024 |
